Close
  Indian J Med Microbiol
 

Figure 5: Forest plot highlighting the side effect profile of the use of evogliptin as compared to controls focusing on (a): Total Adverse Events (TAEs); (b): severe Adverse Events (SAEs); (c): symptomatic hypoglycaemia; and (d): asymptomatic hypoglycaemia

Figure 5: Forest plot highlighting the side effect profile  of the use of evogliptin as compared to controls focusing on (a): Total Adverse Events (TAEs); (b): severe Adverse Events (SAEs); (c): symptomatic hypoglycaemia; and (d): asymptomatic hypoglycaemia